Natural Alternatives International, Inc. (NAII) financial statements (2021 and earlier)
Company profile
| Business Address |
1535 FARADAY AVENUE CARLSBAD, CA 92008-7319 |
| State of Incorp. | DE |
| Fiscal Year End | June 30 |
| SIC | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 Q2 | 9/30/2019 Q1 | 6/30/2019 Q4 | 3/31/2019 Q3 | 12/31/2018 Q2 | 9/30/2018 Q1 | 6/30/2018 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 27 | 29 | 25 | 28 | 30 | 28 | 24 | ||
| Cash and cash equivalents | 27 | 29 | 25 | 28 | 30 | 28 | 24 | ||
| Receivables | 15 | 15 | 17 | 17 | 14 | 14 | 16 | ||
| Inventory, net of allowances, customer advances and progress billings | 23 | 25 | 26 | 27 | 23 | 25 | 24 | ||
| Inventory | 23 | 25 | 26 | 27 | 23 | 25 | 24 | ||
| Derivative instruments and hedges, assets | 2 | 3 | 2 | 3 | |||||
| Other undisclosed current assets | 2 | 2 | 2 | 2 | 4 | 3 | 2 | ||
| Total current assets: | 69 | 73 | 71 | 76 | 71 | 70 | 65 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 20 | 20 | ✕ | ✕ | ✕ | ||||
| Property, plant and equipment | 21 | 21 | 21 | 21 | 20 | 19 | 19 | ||
| Other noncurrent assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Total noncurrent assets: | 41 | 42 | 22 | 22 | 22 | 20 | 20 | ||
| TOTAL ASSETS: | 110 | 115 | 93 | 98 | 93 | 90 | 85 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 11 | 15 | 14 | 18 | 15 | 15 | 14 | ||
| Accounts payable | 5 | 10 | 9 | 12 | 10 | 10 | 10 | ||
| Accrued liabilities | 3 | 2 | 3 | 4 | 2 | 2 | 2 | ||
| Employee-related liabilities | 1 | 1 | 2 | 1 | 2 | 2 | 1 | ||
| Taxes payable | 2 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Total current liabilities: | 11 | 15 | 14 | 18 | 15 | 15 | 14 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 20 | 20 | |||||||
| Operating lease, liability | 20 | 20 | ✕ | ✕ | ✕ | ||||
| Liabilities, other than long-term debt | 2 | 2 | 2 | 2 | 3 | 3 | 3 | ||
| Accounts payable and accrued liabilities | 1 | 1 | 1 | 2 | 2 | 2 | 2 | ||
| Deferred rent credit | 1 | 1 | 1 | ||||||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | ✕ | 1 | 1 | 1 | ||
| Liability, pension and other postretirement and postemployment benefits | 0 | 0 | 0 | 0 | 0 | ||||
| Other liabilities | 1 | 1 | |||||||
| Other undisclosed noncurrent liabilities | 1 | 1 | 1 | 1 | |||||
| Total noncurrent liabilities: | 22 | 23 | 3 | 3 | 3 | 3 | 3 | ||
| Total liabilities: | 33 | 38 | 17 | 21 | 18 | 18 | 17 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 76 | 77 | 76 | 77 | 75 | 72 | 68 | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Treasury stock, value | (9) | (8) | (8) | (8) | (7) | (7) | (7) | ||
| Additional paid in capital | 27 | 27 | 26 | 26 | 26 | 25 | 24 | ||
| Accumulated other comprehensive income (loss) | (0) | 1 | 0 | 1 | 1 | (0) | (1) | ||
| Retained earnings | 59 | 58 | 57 | 58 | 56 | 53 | 51 | ||
| Total stockholders' equity: | 76 | 77 | 76 | 77 | 75 | 72 | 68 | ||
| TOTAL LIABILITIES AND EQUITY: | 110 | 115 | 93 | 98 | 93 | 90 | 85 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 Q2 | 9/30/2019 Q1 | 6/30/2019 Q4 | 3/31/2019 Q3 | 12/31/2018 Q2 | 9/30/2018 Q1 | 6/30/2018 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 29 | 29 | 30 | 35 | 36 | 37 | 39 | |
| Cost of revenue (Cost of Goods and Services Sold) | (24) | (25) | (27) | (29) | (30) | (29) | (33) | |
| Gross profit: | 5 | 4 | 4 | 6 | 6 | 7 | 7 | |
| Operating expenses | (4) | (4) | (4) | (4) | (4) | (4) | (4) | |
| Operating income (loss): | 1 | (0) | (1) | 2 | 2 | 3 | 3 | |
| Nonoperating income (expense) | (0) | 0 | 0 | 1 | 1 | 0 | 1 | |
| Investment income, nonoperating | 0 | 0 | 0 | 0 | 1 | 1 | 0 | |
| Foreign currency transaction gain (loss), before tax | (0) | 0 | (0) | 0 | 0 | (0) | 0 | |
| Income (loss) from continuing operations before income taxes: | 1 | 0 | (0) | 2 | 3 | 3 | 4 | |
| Income tax expense (benefit) | (0) | (0) | 0 | (0) | (1) | (1) | (1) | |
| Net income (loss) available to common stockholders, diluted: | 0 | 0 | (0) | 2 | 2 | 3 | 3 | |
Comprehensive Income ($ in millions)
| 12/31/2019 Q2 | 9/30/2019 Q1 | 6/30/2019 Q4 | 3/31/2019 Q3 | 12/31/2018 Q2 | 9/30/2018 Q1 | 6/30/2018 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 0 | 0 | (0) | 2 | 2 | 3 | 3 | |
| Other undisclosed comprehensive income (loss) | (0) | 0 | ||||||
| Comprehensive income (loss): | 0 | 0 | (0) | 2 | 2 | 3 | 3 | |
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (1) | 0 | (1) | 0 | 1 | 0 | 2 | |
| Comprehensive income (loss), net of tax, attributable to parent: | (0) | 0 | (1) | 2 | 3 | 3 | 5 | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.